HealthEquity, Inc. (HQY)

HealthEquity Income Statement

Financials in millions USD. Fiscal year is February - January.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 30, 2025	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022	Jan 31, 2021
Revenue	1,243	1,200	999.59	861.75	756.56	733.57
Revenue Growth (YoY)	19.21%	20.03%	16.00%	13.90%	3.13%	37.89%
Cost of Revenue	428.59	422.52	376.95	369.81	331.79	318.24
Gross Profit	814.43	777.26	622.64	491.94	424.77	415.33
Selling, General & Admin	212.79	223	182.93	166.32	144.04	134.46
Research & Development	244.86	239.51	218.81	193.38	157.36	124.81
Operating Expenses	570.98	574.39	494.5	454.28	384.2	335.33
Operating Income	243.45	202.87	128.13	37.65	40.57	80
Interest Expense	-63.7	-60.63	-55.46	-48.42	-36.57	-34.88
Interest & Investment Income	12.77	13.91	12.14	1.76	1.5	1.05
Other Non Operating Income (Expenses)	0.9	0.42	0.66	-0.44	1.71	5.08
EBT Excluding Unusual Items	193.42	156.57	85.48	-9.45	7.2	51.25
Merger & Restructuring Charges	-39.67	-40.54	-10.44	-28.65	-75.64	-47.11
Gain (Loss) on Sale of Investments	-	-	-	-	1.69	-
Pretax Income	153.75	116.03	75.04	-38.1	-66.74	4.14
Income Tax Expense	31.94	19.33	19.33	-11.95	-22.45	-4.69
Net Income	121.81	96.7	55.71	-26.14	-44.29	8.83
Net Income to Common	121.81	96.7	55.71	-26.14	-44.29	8.83
Net Income Growth	51.44%	73.58%	-	-	-	-77.73%
Shares Outstanding (Basic)	87	87	86	84	83	74
Shares Outstanding (Diluted)	89	89	87	84	83	76
Shares Change (YoY)	1.53%	2.15%	2.98%	1.57%	9.85%	10.56%
EPS (Basic)	1.40	1.11	0.65	-0.31	-0.53	0.12
EPS (Diluted)	1.37	1.09	0.64	-0.31	-0.53	0.12
EPS Growth	48.80%	70.31%	-	-	-	-79.48%
Free Cash Flow	337.72	337.77	241.13	147.28	132.09	168.53
Free Cash Flow Per Share	3.80	3.80	2.77	1.74	1.59	2.23
Gross Margin	65.52%	64.78%	62.29%	57.09%	56.15%	56.62%
Operating Margin	19.59%	16.91%	12.82%	4.37%	5.36%	10.91%
Profit Margin	9.80%	8.06%	5.57%	-3.03%	-5.85%	1.20%
Free Cash Flow Margin	27.17%	28.15%	24.12%	17.09%	17.46%	22.97%
EBITDA	405.7	365.32	281.21	198.85	177.76	195.91
EBITDA Margin	32.64%	30.45%	28.13%	23.08%	23.49%	26.71%
D&A For EBITDA	162.25	162.45	153.08	161.2	137.19	115.9
EBIT	243.45	202.87	128.13	37.65	40.57	80
EBIT Margin	19.59%	16.91%	12.82%	4.37%	5.36%	10.91%
Effective Tax Rate	20.78%	16.66%	25.76%	-	-	-
Revenue as Reported	1,243	1,200	999.59	861.75	756.56	733.57

Updated Jun 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q